News

Tradr ETFs Introduces Options Trading on New Leveraged ETFs

Tradr ETFs Introduces Options Trading on New Leveraged ETFs

Options Trading Now Offered on Tradr ETFs

In response to the growing demand for innovative trading solutions, Tradr ETFs has announced the introduction of options trading on its newly launched leveraged ETFs. This expansion enhances the trading capabilities for investors eager to harness the potential of 2X Leveraged Daily ETFs tied to D-Wave Quantum, Tempus AI, and AppLovin.

Overview of the New ETFs

Tradr ETFs has expanded its offerings with three innovative products: the Tradr 2X Long QBTS Daily ETF (Cboe: QBTX), Tradr 2X Long TEM Daily ETF (Cboe: TEMT), and the Tradr 2X Long APP Daily ETF (Nasdaq: APPX). These assets were designed specifically for sophisticated investors and professional traders seeking a leveraged exposure to rapidly growing sectors of the market.

Market Response and Performance

Since their recent launch, these ETFs have experienced tremendous interest, demonstrating significant daily trading activity. The QBTX ETF has particularly stood out, emerging as one of the fastest-growing ETFs of the year, largely driven by a notable increase in D-Wave Quantum shares. With approximately $12.5 million in assets and an average daily trading volume exceeding 403,000 shares, QBTX proves to be a player to watch.

Meanwhile, APPX and TEMT have also quickly attracted significant asset growth, with APPX accumulating over $13.5 million in assets and TEMT drawing approximately $11.5 million in assets since their introductions. This impressive performance underscores traders' willingness to explore leveraged investments in emerging technologies such as quantum computing, AI-driven solutions, and digital advertising.

Enhanced Trading Flexibility

Matt Markiewicz, Head of Product and Capital Markets at Tradr ETFs, emphasized the importance of options trading stating, "The strong early demand for QBTX, TEMT and APPX highlights how traders are increasingly on the hunt for tools that let them express high conviction views in robust-growth, high-volatility stories." The introduction of options allows investors to better manage risk, hedge exposure, and take directional positions that align with their market strategies.

Understanding Leveraged ETFs

Investing in leveraged ETFs carries unique considerations compared to traditional funds. These products are designed primarily for short-term trading and may experience higher volatility. With leverage magnifying both gains and losses, understanding the intricacies of these instruments is essential for potential investors.

Risks and Considerations

Investors should be aware that leveraging can lead to substantial losses if the underlying asset moves unfavorably. In fact, a 50% decline in the ETF's underlying asset could result in a complete loss of investment for those long in the fund. As such, these investments require active monitoring.

Furthermore, ETF performance can diverge significantly from its benchmark over extended periods. Investors committed to trading these ETFs should continuously assess their approach and be mindful of the trading costs associated with frequent transactions.

About Tradr ETFs

Tradr ETFs is focused on designing investment products for those who are committed to taking thoughtful positions in the market. They specialize in creating leveraged and inverse ETFs that allow for both long and short exposures to various equities.

As the market continues to evolve with technologies like quantum computing and AI, products from Tradr ETFs are set to align with these cutting-edge industries, empowering investors with new opportunities to advance their investment strategies.

Frequently Asked Questions

What are the newly launched ETFs from Tradr ETFs?

The newly launched ETFs are the Tradr 2X Long QBTS Daily ETF (Cboe: QBTX), Tradr 2X Long TEM Daily ETF (Cboe: TEMT), and Tradr 2X Long APP Daily ETF (Nasdaq: APPX).

Why is options trading significant for these ETFs?

Options trading provides investors with greater flexibility to manage their risk, hedge exposure, and build strategic positions aligned with market changes.

What risks should investors consider with leveraged ETFs?

Investors should consider that leveraged ETFs typically offer higher volatility and the potential for substantial losses if underlying assets decline significantly.

How long should investors hold these ETFs?

These ETFs are designed primarily for short-term trading due to their leveraged nature; therefore, active management is recommended.

Where can investors find more information about Tradr ETFs?

Investors can visit the official website for detailed information about Tradr ETFs and the risks involved with leveraged products.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Arclin's Bold Bet: Expanding Nomex Capacity in Spain

Updated Category News Views 5

Arclin's Strategic Move for Nomex® Expansion Looks like Arclin’s not messing around. They're throwing some serious cash down in Asturias, Spain, to ramp up production of Nomex®—a material hotter than a blacktop in July with demand surging across aerospace, electric vehicles, and defense sectors. "When we bought the Nomex® business, we committed to investing in its...

Continue Reading
Unicycive Faces Stock Plunge and Legal Woes After FDA Setback

Updated Category News Views 5

Unicycive's Rough Ride: Not Just a Bump Picture this: Your stock takes a nosedive over 39% in a day, just after a critical drug application gets slammed by the FDA—for the second time. That’s the story with Unicycive Therapeutics, Inc., ticker NASDAQ: UNC, a company that's been handing out one nail-biting moment after another to its investors. It's not just a minor...

Continue Reading
ELEGOO's M1 Ultra: Bridging Gap in 3D Scanning Tech

Updated Category News Views 0

A Leap in 3D Scanning: Say Hello to M1 Ultra ELEGOO isn't just fiddling with a toy here—this Shenzhen-based juggernaut is rolling out the M1 Ultra on October 29, 2026, and it's causing quite a stir. While the stock market doesn't see immediate tremors from every shiny new gadget, there’s something to say when a company that pulled over $300 million in sales last year...

Continue Reading
Side Bolsters Art Division with Roboto Acquisition

Updated Category News Views 7

Breaking Into China's Game Art Market The gaming industry's latest buzz centers around Side's acquisition of Roboto Entertainment, a boutique art studio known for crafting immersive game environments. This isn't just another headline grab—this move puts Side smack dab in the heart of China's burgeoning game market with a fresh Chengdu base. Expansion With Strategic...

Continue Reading
S&T Bancorp Hits Record Highs in Q3 2026

Updated Category News Views 3

Surpassing Expectations with Record Metrics Well, if it isn’t another stellar quarter for S&T Bancorp (NASDAQ:STBA). The folks over in Indiana, PA, just threw down some serious numbers. The third quarter of 2026 saw net income climbing to $38.6 million, up from $36.6 million last quarter. That's a decent hike if you ask me. But what really stole the spotlight here was...

Continue Reading
Savarese Joins RID to Drive Diagnostic Innovation

Updated Category News Views 5

A Seasoned Leader Bolsters RID's Ambitions Mario Savarese has joined Rapid Infection Diagnostics Inc.'s Strategic Advisory Board, and let me tell ya, this move's got potential. Appointing a heavyweight like Savarese as an advisor isn’t just a nod to his hefty resume. It’s about vaulting a burgeoning company into the big leagues. He's got over 20 years steering a ship...

Continue Reading
Tairex's AI System Targets Global Healthcare Gaps

Updated Category News Views 6

AI Meets Human Expertise in Clinical Decision-Making Look, in the labyrinth of healthcare, we’re seeing a revolution with AI stepping in—not to replace the doctor, but to stand alongside them like a trusty assistant. Tairex, from the halls of Tsinghua University's Institute for AI Industry Research (AIR), has thrown its hat into this ring by unveiling their...

Continue Reading
Montega Kicks Off Agilyx Sponsored Equity Research

Updated Category News Views 1

A Fresh Take on Agilyx's Market Standing Alright, folks. Agilyx ASA just got a new ticket for the analytical rodeo as Montega AG dives into sponsored equity research on the company. For those who aren't fluent in the arcane dialect of stock enthusiasts like yours truly, this means Agilyx now has another sharp set of eyes evaluating their every move, and let me tell you,...

Continue Reading
Nel ASA Welcomes Morten Holum as New CEO by 2027

Updated Category News Views 7

Nel ASA's New Leader Announced In the latest shake-up at Nel ASA (OSE: NEL), Morten Holum is getting ready to take the reins as CEO. By May 1, 2027, Holum will step into the shoes left by Håkon Volldal. And folks, this isn't your average leadership swap. Holum brings a hefty toolkit to this hydrogen powerhouse, having been part of the action across the hydrogen value...

Continue Reading
Amcor's Q3 2026 Results Loom: What's at Stake?

Updated Category News Views 3

Anticipation Builds for Amcor's Q3 2026 Financials Well, here we are again, staring down the barrel of another quarterly earnings report from Amcor plc (NYSE: AMCR). They've circled November 4th, 2026, in red on their calendars to dish out the numbers after the U.S. market's last bell rings. Investors, analysts, and the peanut gallery will be tuning in, and why not? At a...

Continue Reading

Top 5 Most Recently Viewed Articles

Ontex Group to Announce Shareholding Details Soon

Updated Category News Views 51

Significant Shareholding Notification by Ontex Group NV Ontex Group NV is committed to transparency and compliance with regulatory requirements. Recently, the company disclosed a significant shareholding notification that it received regarding Black Creek Investment Management Inc. This notification aligns with the Belgian Law concerning significant shareholdings in...

Continue Reading
TriNet Set to Announce First Quarter Results Soon

Updated Category News Views 154

TriNet's Upcoming Financial Report Announcement TriNet (NYSE: TNET), a prominent provider of human resources solutions tailored for small and medium-sized businesses (SMBs), is gearing up to reveal its financial results for the first quarter previously ended on March 31. The announcement is set to take place before the U.S. market opens on April 25. Details of the...

Continue Reading
PTC Therapeutics: Upcoming Q3 2025 Financial Results Call

Updated Category News Views 166

PTC Therapeutics Plans Third Quarter 2025 Financial Call PTC Therapeutics, Inc. (NASDAQ: PTCT) has announced that it will host a conference call to discuss its financial results for the third quarter of 2025. This upcoming event is set to take place on November 4 at 4:30 p.m. ET. It promises to provide valuable insights into the company's performance and strategic...

Continue Reading
Enhancing Maritime Safety with PntGuard™ Against Spoofing Threats

Updated Category News Views 201

Introducing PntGuard™ for Enhanced Maritime Security PntGuard™ is a revolutionary maritime-security solution designed to protect vessels from the dangers of GNSS spoofing and jamming. As the maritime sector faces growing threats from malicious disruptions of GNSS signals, PntGuard™ stands as a beacon of reliability, ensuring crews can navigate with confidence. This...

Continue Reading
Scienture Holdings Expands Market Reach with Arbli™ Agreements

Updated Category News Views 162

Scienture Holdings Enhances Healthcare Access with New Agreements Signifying a potential reach into about 20% of the U.S. institutional market, Scienture Holdings, Inc. (NASDAQ: SCNX) is paving the way for Arbli™ (losartan potassium) across a range of healthcare facilities. The U.S. losartan market, valued at $256 million annually, witnesses around 71 million...

Continue Reading